PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

RESEARCH ALERT: City of Hope scientists identify new therapeutic target for metastatic cancer

Novel study investigates ways to halt metabolic adaptation in malignant cells

2023-09-08
(Press-News.org) FINDINGS
In a recent study led by Lei Jiang, Ph.D., an assistant professor of molecular and cellular endocrinology, a team of researchers from City of Hope and the University of Texas Southwestern Medical Center, found a potential new target for treating patients with metastatic cancer. Their findings were published in the August 29 issue of the journal Cell Reports. 

The goal of the team’s study was to elucidate the role of reductive carboxylation in redox metabolism, a process believed to be important for metastatic cancer. Reductive carboxylation is best known as a metabolic pathway that provides a molecule called acetyl-CoA so that it can be turned into lipids, which is mediated by fatty acid synthase (FASN). The FASN-mediated lipogenesis process supports rapid growth in most proliferating cancer cells, and increased FASN expression has been viewed as a metabolic feature of cancer cells. Thus, FASN is considered a potential target to block tumor growth. 

In their new paper, Jiang et al. used lung cancer cells to show that FASN inhibition induces reductive carboxylation, which further increases redox capacity (a process central to metabolism) in metastatic cancer cells. In this setting, reductive carboxylation induces a net cytosol-to-mitochondria citrate flux in FASN-deficient cells. This was surprising because citrate flux across mitochondria—one way that cancer cells gain energy—has been previously known to only go in the mitochondria-to-cytosol direction. Importantly, blocking this cytosol-to-mitochondria citrate flux effectively induces oxidative stress and cell death in metastatic cancer cells. 
 
BACKGROUND 
Previous work by Jiang and others found that adaptation to anchorage independence in cancer cells (meaning they can proliferate without another surface to anchor with) requires a fundamental metabolic change in the citrate metabolism—a lipogenic precursor for de novo lipogenesis—via reductive carboxylation to suppress oxidative stress. However, the role of fatty acid synthase (FASN), a critical lipogenic enzyme, in reductive carboxylation during metastatic progression was unclear prior to the recent study.

IMPACT
Building on prior research, this study provides additional data to support Jiang and his team’s belief that targeting the cytosol-to-mitochondria citrate flux process can be an effective therapy for treating cancer patients with metastasis. Since the role of FASN in metastasis is context dependent, the team plans to test whether a similar mechanism exists in other cancer types beyond lung cancer.

AUTHORS
At City of Hope, Jiang is an assistant professor of molecular and cellular endocrinology. His research is focused on investigating the molecular mechanisms that regulate nutrient homeostasis during the development and progress of metabolic diseases like cancer. Wenting Dai, Ph.D. is first author on the study who performed and published the research during her postdoctoral training at City of Hope. 

FUNDING
The research was supported by City of Hope Medical Center. Scientists who worked on the study are supported by grants from National Cancer Institute, the Cancer Prevention and Research Institute of Texas, the National Institutes of Health and the American Diabetes Association Junior Faculty Development Award.

About City of Hope
City of Hope's mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and treatment facilities in Atlanta, Chicago and Phoenix. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHope. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn.

END


ELSE PRESS RELEASES FROM THIS DATE:

McWilliams School of Biomedical Informatics researchers awarded $3.4M NIH grant to understand link between chronic health conditions and Alzheimer's disease

McWilliams School of Biomedical Informatics researchers awarded $3.4M NIH grant to understand link between chronic health conditions and Alzheimers disease
2023-09-08
A three-year, $3.4 million grant to investigate how Alzheimer’s disease is connected to multiple chronic diseases has been awarded to UTHealth Houston researchers by the National Institute on Aging, part of the National Institutes of Health. To study this, a team led by Xiaoqian Jiang, PhD, principal investigator and professor and chair in the Department of Health Data Science and Artificial Intelligence with McWilliams School of Biomedical Informatics at UTHealth Houston, will build risk trajectory maps for patients using clinical data and electronic health records. Specifically, they will develop electronic health records ...

SwiftPharma and the Population Council pursue agreement to manufacture Griffithsin needed for the development of a fast-dissolving insert for protection against HIV

2023-09-08
September 8, 2023 – SwiftPharma, a Belgium-based manufacturer, and the Population Council, a global nonprofit research organization, have signed a Manufacturing Master Service Agreement for the plant-based manufacture of Griffithsin to further the Council’s development of a Griffithsin fast-dissolving vaginal insert for protection against HIV.     The Population Council has been developing a non-antiretroviral HIV-prevention method containing Griffithsin (GRFT) in a fast-dissolving insert (FDI). This Griffithsin FDI is an on-demand, user-controlled, portable prevention technology in early development ...

What defines a safety-net hospital?

2023-09-08
Safety-net hospitals have a common mission to provide care for Medicaid beneficiaries and those who are uninsured, but there’s no universal definition for these hospitals—complicating efforts to allocate funding. In a new analysis published in JAMA Network Open and led by researchers at the NYU School of Global Public Health, the research team looked at five established definitions for safety-net hospitals and found that different criteria captured varying hospitals and characteristics. As a result, when the Centers for Medicaid and Medicare Services (CMS) use one definition ...

Heatwaves hitting Antarctica too

Heatwaves hitting Antarctica too
2023-09-08
The world saw another year full of extreme weather events resulting from climate change in 2022, from intense storms to soaring temperatures and rising sea levels. Antarctica was no exception, according to new research published this week.    In the 33rd annual State of the Climate report, an international assessment of the global climate published Sept. 6 in the Bulletin of the American Meteorological Society, CU Boulder researchers report that the planet’s coldest and driest continent experienced both an unprecedented heatwave and extreme precipitation last year.  “My hope is that the public starts to see both the fragility and complexity of these ...

These worms have rhythm

These worms have rhythm
2023-09-08
There’s a rhythm to developing life. Growing from a tiny cell cluster into an adult organism takes precise timing and control. The right genes must turn on at the right time, for the right duration, and in the correct order. Losing the rhythm can lead to diseases like cancer. So, what keeps every gene on beat? Cold Spring Harbor Laboratory (CSHL) Professor Christopher Hammell has found that in the worm C. elegans, this genetic orchestra has no single conductor. Instead, a quartet of molecules works in concert to time each developmental stage. Hammell says this process shares some similarities with the circadian clocks that control human ...

Sleep-wake therapy gives new hope for teens with depression

2023-09-08
Sleep-Wake Therapy Gives New Hope for Teens with Depression  Promoting healthy sleep in teen night owls brings adolescents’ biology and school demands in alignment.  School systems aren’t built for kids who fall asleep and wake up late, the so-called “night owls,” which may help explain why this group of teens is more prone to depression.  Now, researchers at UC San Francisco have found a way to help these kids adjust to their natural sleep-cycle rhythms while still fulfilling their school responsibilities. The findings are a welcome sign for adolescents with ...

Study explores an underappreciated way warmer temperatures will impact ecosystems: Decomposition

Study explores an underappreciated way warmer temperatures will impact ecosystems: Decomposition
2023-09-08
Our world is changing, and warming temperatures will alter our natural ecosystems. Some of these changes will be straightforward, like animal ranges creeping northward as they strive to maintain their ideal temperatures. But other changes will be more complicated, as warming sets off complex chain reactions that reverberate through these systems. An important process in ecosystems is the decomposition of plant litter, in which dead plant material is broken down by animals, fungi, and microbes, making its nutrients accessible to the next generation of plants. How quickly this breakdown happens — the decomposition ...

UMBC team of data scientists named a tools competition winner

2023-09-08
Baltimore – A team of four data scientists from the University of Maryland, Baltimore County, was named today as one of 32 winners of the Tools Competition, one of the largest education technology (edtech) competitions in the world that awarded more than $4 million to winners this year.  The team was a winner in the DARPA AI Tools for Adult Learning opportunity, which sought artificial intelligence-powered tools to help adults learn complex topics necessary for the current and future national security workforce (e.g., AI engineering ...

Synchrotron studies change the composition of the Earth’s core

2023-09-08
In work published in Science Advances, a team of researchers have determined a new pressure scale, which is critical for understanding the Earth’s composition. Using x-rays from a uniquely powerful spectrometer at RIKEN’s SPring-8 Center they avoided some of the large approximations of previous work, discovering that the previous scale overestimated pressure by more than 20% at 230 gigapascals (2.3 million atmospheres) - a pressure reached in Earth’s core. This is similar to someone running a marathon that they thought was 42 kilometers, but finding they had only really run 34 kilometers. While 20% might seem like a modest correction, it has big implications.  An accurate ...

Applications now open for early-career Latin American science journalists to receive EurekAlert! Fellowships and attend the AAAS Annual Meeting

Applications now open for early-career Latin American science journalists to receive EurekAlert! Fellowships and attend the AAAS Annual Meeting
2023-09-08
The EurekAlert! Fellowships for International Science Reporters are back and now accepting applications from early-career Latin American science journalists. Two fellows will be selected to receive travel funding from EurekAlert! to attend the 2024 AAAS Annual Meeting, taking place February 15-17, 2024 in Denver, Colorado. Learn more about who is eligible and how to apply on our website. The application deadline is October 5, 2023 at 11:59 p.m. US Eastern Time. The American Association for the Advancement of Science (AAAS) ...

LAST 30 PRESS RELEASES:

Dr. Gianluca Ianiro wins a prestigious grant from the European Research Council (ERC)

‘Rogue’ DNA rings reveal earliest clues to deadly brain cancer’s growth

Clinical study deepens understanding of mesothelioma and opens the door to potential treatment options

New study and major data updates expand the Kids First data ecosystem

Seaweed snare: Sargassum stops sea turtle hatchlings in their tracks

Scientists uncover key to decoupling economic growth from pollution in developing countries

Frailty fuels gut imbalance and post-surgery gastrointestinal risks

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

[Press-News.org] RESEARCH ALERT: City of Hope scientists identify new therapeutic target for metastatic cancer
Novel study investigates ways to halt metabolic adaptation in malignant cells